tiprankstipranks
Trending News
More News >
Beta Bionics, Inc. (BBNX)
NASDAQ:BBNX
US Market
Advertisement

Beta Bionics, Inc. (BBNX) Stock Forecast & Price Target

Compare
21 Followers
See the Price Targets and Ratings of:

BBNX Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
4 Buy
3 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Beta
Bionics, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BBNX Stock 12 Month Forecast

Average Price Target

$21.87
▲(16.89% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Beta Bionics, Inc. in the last 3 months. The average price target is $21.87 with a high forecast of $30.00 and a low forecast of $17.00. The average price target represents a 16.89% change from the last price of $18.71.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","31":"$31","15.25":"$15.25","20.5":"$20.5","25.75":"$25.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$17.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,15.25,20.5,25.75,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,17.446153846153845,18.49230769230769,19.538461538461537,20.584615384615383,21.63076923076923,22.676923076923075,23.723076923076924,24.769230769230766,25.815384615384616,26.86153846153846,27.907692307692308,28.953846153846154,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.82076923076923,17.24153846153846,17.662307692307692,18.083076923076923,18.503846153846155,18.924615384615386,19.345384615384617,19.766153846153845,20.186923076923076,20.607692307692307,21.02846153846154,21.44923076923077,{"y":21.87,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.446153846153845,16.49230769230769,16.538461538461537,16.584615384615383,16.63076923076923,16.676923076923075,16.723076923076924,16.76923076923077,16.815384615384616,16.861538461538462,16.907692307692308,16.953846153846154,{"y":17,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.81,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":23.81,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.97,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.14,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.94,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$30.00Average Price Target$21.87Lowest Price Target$17.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on BBNX
TR | OpenAI - 4o
TR | OpenAI - 4o
$18
Hold
-3.79%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
Truist Financial Analyst forecast on BBNX
Truist Financial
Truist Financial
$26$21
Buy
12.24%
Upside
Reiterated
07/30/25
Truist Financial Reaffirms Their Buy Rating on Beta Bionics, Inc. (BBNX)
Robert W. Baird Analyst forecast on BBNX
Robert W. Baird
Robert W. Baird
$15$17
Hold
-9.14%
Downside
Reiterated
07/30/25
Beta Bionics price target raised to $17 from $15 at BairdBeta Bionics price target raised to $17 from $15 at Baird
Leerink Partners Analyst forecast on BBNX
Leerink Partners
Leerink Partners
$26$28
Buy
49.65%
Upside
Reiterated
07/30/25
Beta Bionics, Inc.: Strong Commercial Execution and Promising Growth Prospects Drive Buy Rating
Lake Street Analyst forecast on BBNX
Lake Street
Lake Street
$30
Buy
60.34%
Upside
Reiterated
07/30/25
Beta Bionics, Inc. (BBNX) Receives a Buy from Lake Street
Bank of America Securities Analyst forecast on BBNX
Bank of America Securities
Bank of America Securities
Buy
Reiterated
07/03/25
Bank of America Securities Keeps Their Buy Rating on Beta Bionics, Inc. (BBNX)
Goldman Sachs Analyst forecast on BBNX
Goldman Sachs
Goldman Sachs
$17.24
Hold
-7.86%
Downside
Initiated
05/30/25
Goldman Sachs Initiates a Hold Rating on Beta Bionics, Inc. (BBNX)
Wolfe Research Analyst forecast on BBNX
Wolfe Research
Wolfe Research
$20
Buy
6.89%
Upside
Initiated
05/29/25
Wolfe Research Initiates a Buy Rating on Beta Bionics, Inc. (BBNX)
Piper Sandler Analyst forecast on BBNX
Piper Sandler
Piper Sandler
$26
Buy
38.96%
Upside
Reiterated
05/07/25
Stifel Nicolaus Analyst forecast on BBNX
Stifel Nicolaus
Stifel Nicolaus
$25
Buy
33.62%
Upside
Reiterated
04/04/25
Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus
Ladenburg Thalmann & Co. Analyst forecast on BBNX
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$31
Buy
65.69%
Upside
Initiated
02/20/25
Beta Bionics initiated with a Buy at LadenburgBeta Bionics initiated with a Buy at Ladenburg
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on BBNX
TR | OpenAI - 4o
TR | OpenAI - 4o
$18
Hold
-3.79%
Downside
Reiterated
08/19/25
AI Generated ArticleAI Generated Article
Truist Financial Analyst forecast on BBNX
Truist Financial
Truist Financial
$26$21
Buy
12.24%
Upside
Reiterated
07/30/25
Truist Financial Reaffirms Their Buy Rating on Beta Bionics, Inc. (BBNX)
Robert W. Baird Analyst forecast on BBNX
Robert W. Baird
Robert W. Baird
$15$17
Hold
-9.14%
Downside
Reiterated
07/30/25
Beta Bionics price target raised to $17 from $15 at BairdBeta Bionics price target raised to $17 from $15 at Baird
Leerink Partners Analyst forecast on BBNX
Leerink Partners
Leerink Partners
$26$28
Buy
49.65%
Upside
Reiterated
07/30/25
Beta Bionics, Inc.: Strong Commercial Execution and Promising Growth Prospects Drive Buy Rating
Lake Street Analyst forecast on BBNX
Lake Street
Lake Street
$30
Buy
60.34%
Upside
Reiterated
07/30/25
Beta Bionics, Inc. (BBNX) Receives a Buy from Lake Street
Bank of America Securities Analyst forecast on BBNX
Bank of America Securities
Bank of America Securities
Buy
Reiterated
07/03/25
Bank of America Securities Keeps Their Buy Rating on Beta Bionics, Inc. (BBNX)
Goldman Sachs Analyst forecast on BBNX
Goldman Sachs
Goldman Sachs
$17.24
Hold
-7.86%
Downside
Initiated
05/30/25
Goldman Sachs Initiates a Hold Rating on Beta Bionics, Inc. (BBNX)
Wolfe Research Analyst forecast on BBNX
Wolfe Research
Wolfe Research
$20
Buy
6.89%
Upside
Initiated
05/29/25
Wolfe Research Initiates a Buy Rating on Beta Bionics, Inc. (BBNX)
Piper Sandler Analyst forecast on BBNX
Piper Sandler
Piper Sandler
$26
Buy
38.96%
Upside
Reiterated
05/07/25
Stifel Nicolaus Analyst forecast on BBNX
Stifel Nicolaus
Stifel Nicolaus
$25
Buy
33.62%
Upside
Reiterated
04/04/25
Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus
Ladenburg Thalmann & Co. Analyst forecast on BBNX
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$31
Buy
65.69%
Upside
Initiated
02/20/25
Beta Bionics initiated with a Buy at LadenburgBeta Bionics initiated with a Buy at Ladenburg
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Beta Bionics, Inc.

1 Month
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
+6.33%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +6.33% per trade.
3 Months
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+4.90%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +4.90% per trade.
1 Year
Mike KratkyLeerink Partners
Success Rate
3/4 ratings generated profit
75%
Average Return
+16.07%
reiterated a buy rating last month
Copying Mike Kratky's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +16.07% per trade.
2 Years
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+16.07%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +16.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BBNX Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
8
13
7
8
3
Buy
6
1
3
5
4
Hold
2
5
6
13
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
19
16
26
20
In the current month, BBNX has received 7 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. BBNX average Analyst price target in the past 3 months is 21.87.
Each month's total comprises the sum of three months' worth of ratings.

BBNX Financial Forecast

BBNX Earnings Forecast

Next quarter’s earnings estimate for BBNX is -$0.42 with a range of -$0.52 to -$0.32. The previous quarter’s EPS was -$0.39. BBNX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.13% of the time in the same period. In the last calendar year BBNX has Outperformed its overall industry.
Next quarter’s earnings estimate for BBNX is -$0.42 with a range of -$0.52 to -$0.32. The previous quarter’s EPS was -$0.39. BBNX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.13% of the time in the same period. In the last calendar year BBNX has Outperformed its overall industry.

BBNX Sales Forecast

Next quarter’s sales forecast for BBNX is $23.92M with a range of $23.50M to $24.68M. The previous quarter’s sales results were $23.24M. BBNX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year BBNX has Outperformed its overall industry.
Next quarter’s sales forecast for BBNX is $23.92M with a range of $23.50M to $24.68M. The previous quarter’s sales results were $23.24M. BBNX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.91% of the time in the same period. In the last calendar year BBNX has Outperformed its overall industry.

BBNX Stock Forecast FAQ

What is BBNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Beta Bionics, Inc.’s 12-month average price target is 21.87.
    What is BBNX’s upside potential, based on the analysts’ average price target?
    Beta Bionics, Inc. has 16.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BBNX a Buy, Sell or Hold?
          Beta Bionics, Inc. has a consensus rating of Moderate Buy which is based on 4 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Beta Bionics, Inc.’s price target?
            The average price target for Beta Bionics, Inc. is 21.87. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $30.00 ,the lowest forecast is $17.00. The average price target represents 16.89% Increase from the current price of $18.71.
              What do analysts say about Beta Bionics, Inc.?
              Beta Bionics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of BBNX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis